Clorox (NYSE:CLX) Rating Lowered to Hold at StockNews.com

Clorox (NYSE:CLX) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Sunday.

CLX has been the subject of several other reports. Evercore ISI decreased their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. DA Davidson raised their price target on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Barclays lifted their price objective on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Finally, TD Cowen raised Clorox from a “sell” rating to a “hold” rating and increased their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Five analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $155.38.

Clorox Price Performance

Shares of CLX opened at $157.74 on Friday. Clorox has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a market capitalization of $19.53 billion, a P/E ratio of 54.96, a price-to-earnings-growth ratio of 3.04 and a beta of 0.42. The firm has a 50 day moving average of $164.58 and a 200 day moving average of $155.17. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the company earned $0.49 EPS. The company’s quarterly revenue was up 27.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Clorox will post 6.85 earnings per share for the current fiscal year.

Institutional Trading of Clorox

Hedge funds and other institutional investors have recently modified their holdings of the company. Prospera Private Wealth LLC bought a new position in Clorox in the 3rd quarter worth $27,000. Trifecta Capital Advisors LLC boosted its stake in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after acquiring an additional 130 shares during the period. Continuum Advisory LLC grew its position in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares in the last quarter. Quarry LP raised its stake in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC purchased a new position in Clorox in the 3rd quarter worth approximately $48,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.